Related Experiment Video
Updated: Jun 16, 2026

Synthesis of Masarimycin, a Small Molecule Inhibitor of Gram-Positive Bacterial Growth
Published on: January 7, 2022
Cell-wall-deficient bacteria: a major etiological factor for psoriasis?
Guo-Li Wang1, Xiu-Yun Li, Ming-Yi Wang
1Department of Clinical Laboratory, Weihai Municipal Hospital Affiliated to Dalian Medical University, Weihai, Shandong 264200, China. ways1117@sohu.com
Background:
Psoriasis is a common inflammatory skin disease, yet knowledge of the factors that may induce, trigger, or exacerbate psoriasis is not fully delineated. Recent advances have improved our understanding of the link between psoriasis and cell-wall-deficient bacteria (CWDB) infections. In the present study we assessed the prevalence of CWDB infection in patients with psoriasis.
Methods:
The carriage rate of CWDB in the tonsil or pharynx of psoriasis patients, chronic tonsillitis patients and controls were investigated using hypertonic medium. Psoriasis patients with CWDB were randomly assigned to two groups and respectively treated with antibiotics or systemic therapy without antibiotic. Human peripheral blood mononuclear cells (PBMC) from psoriasis patients, chronic tonsillitis patients and control subjects were stimulated with bacteria antigens and extra-cellular levels of interferon-gamma (IFN-gamma) and interleukin (IL)-10 were measured in the supernatants using the ELISA technique, in vitro. Meanwhile, the proliferation ability of PBMC to respond to bacteria antigens was detected by MTT assay.
Results:
CWDB were isolated from 74.2% of psoriasis patients, 23.5% of chronic tonsillitis patients and only 6.3% of controls. Antibiotic therapy was appropriate for approximately 80% of psoriasis patients with CWDB infection, and in only 8.9% psoriasis patients CWDB infection was detected after antibiotic therapy. Meanwhile, our study showed that CWDB and wide-type bacteria did remarkably enhance the production of IFN-gamma, in vitro, and PBMC proliferation.
Conclusion:
CWDB infection may be a virtual triggering factor in psoriasis by regulating T-cell activation.
Insights
Cell-wall-deficient bacteria (CWDB) infections are prevalent in psoriasis patients, potentially triggering the inflammatory skin disease. Antibiotic treatment effectively reduced CWDB in most patients, suggesting a role in T-cell activation.
Area of Science:
- Dermatology
- Immunology
- Microbiology
Background:
- Psoriasis is a common inflammatory skin condition with incompletely understood triggers.
- Emerging research highlights a connection between psoriasis and infections caused by cell-wall-deficient bacteria (CWDB).
Purpose of the Study:
- To investigate the prevalence of CWDB infections in individuals with psoriasis.
- To explore the immunological response to CWDB in psoriasis patients.
Main Methods:
- Assessed CWDB carriage rates in the tonsils/pharynx of psoriasis patients, chronic tonsillitis patients, and controls.
- Administered antibiotic or non-antibiotic systemic therapy to psoriasis patients with CWDB.
- Measured interferon-gamma (IFN-gamma) and interleukin-10 (IL-10) levels and peripheral blood mononuclear cell (PBMC) proliferation in response to bacterial antigens in vitro.
Main Results:
- CWDB were found in 74.2% of psoriasis patients, compared to 23.5% in chronic tonsillitis and 6.3% in controls.
- Antibiotic therapy was effective in approximately 80% of psoriasis patients, with only 8.9% showing persistent CWDB infection.
- Both CWDB and wide-type bacteria significantly increased IFN-gamma production and PBMC proliferation.
Conclusions:
- CWDB infection is a potential triggering factor in psoriasis.
- CWDB may influence psoriasis pathogenesis by modulating T-cell activation.
Related Concept Videos
Archaeal Cell Wall
Bacterial Cell Wall
Inhibitors of Gram-positive Cell Wall Synthesis
Plant Cell Wall
Plant Cell Wall
Bacterial Phylum Tenericutes